About Dayton Oncology & Hematology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Dayton Oncology & Hematology
During the past decade, Dayton Oncology & Hematology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer
1996-05-01
Completed
342
Chemotherapy Plus Surgery in Treating Women With Breast Cancer
1996-10-01
2009-03-01
Completed
450
Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung Cancer
2001-10-01
Unknown status
Evaluation of Safety and Efficacy of TOCOSOL(R) Paclitaxel as Initial Treatment for Metastatic Breast Cancer
2004-10-01
2007-09-01
Completed
47
A Study to Assess the Safety and Preliminary Efficacy of PT-523 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
2008-04-01
2011-09-01
Withdrawn
0
An Open-label, Randomized, Phase II Study of the Efficacy and Safety of Indisulam (E7070) in Combination With Capecitabine
2004-12-01
2007-09-01
Terminated
62
E7389 Versus Treatment of Physician's Choice in Patients With Locally Recurrent or Metastatic Breast Cancer
2006-11-01
2013-06-01
Completed
762
A Study of Pertuzumab in Combination With Herceptin in Patients With HER2 Positive Breast Cancer.
2006-06-26
2014-09-22
Completed
417
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Dayton Oncology & Hematology" #1 sponsor was "Point Therapeutics" with 2 trials, followed by "Abbott" with 1 trials
sponsored, "Agennix" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "CytRx"
with 1 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Dayton Oncology & Hematology"
#1 collaborator was "US Oncology Research" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Dayton Oncology & Hematology
According to Clinical.Site data, the most researched conditions in "Dayton Oncology & Hematology" are
"Lung Cancer" (2 trials), "Pancreatic Cancer" (2 trials), "Adenocarcinoma" (1 trials), "Carcinoma, Non-Small Cell Lung" (1 trials) and "Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Dayton Oncology & Hematology" in a lesser frequency.
Clinical Trials Intervention Types at Dayton Oncology & Hematology
Most popular intervention types in "Dayton Oncology & Hematology" are "Drug" (10 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Prednisone" (2 trials), "ABT-751" (1 trials), "Bortezomib" (1 trials), "Dasatinib" (1 trials) and "Dexamethasone" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Dayton Oncology & Hematology
The vast majority of trials in "Dayton Oncology & Hematology" are
9 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Dayton Oncology & Hematology
Currently, there are NaN active trials in "Dayton Oncology & Hematology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Dayton Oncology & Hematology,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Dayton Oncology & Hematology, 1 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".